Comparing Insulin Types for Type 2 Diabetes Management
Author Information
Author(s): Gordon J, Pockett R D, Tetlow A P, McEwan P, Home P D
Primary Institution: School of Population Health and Clinical Practice, University of Adelaide
Hypothesis
What are the outcomes of different insulin preparations in people with type 2 diabetes starting insulin therapy?
Conclusion
People starting on NPH insulin had a modest disadvantage in glycaemic control compared to other insulins, with glargine showing the best HbA1c reduction.
Supporting Evidence
- Insulin therapy led to a significant reduction in HbA1c levels after 12 months.
- Patients on glargine had the best reduction in HbA1c compared to NPH.
- Weight gain was observed across all insulin types, with the highest gain in the premix group.
- Persistence with therapy was highest for premix insulin.
Takeaway
This study looked at how different types of insulin help people with diabetes. It found that some insulins work better than others for lowering blood sugar.
Methodology
This was a retrospective observational study using data from a UK primary care database, analyzing changes in HbA1c, body weight, and insulin doses over 12 months.
Potential Biases
Unknown biases may affect which patients received which type of insulin.
Limitations
The study may have biases due to the observational nature and the reliance on patient-reported hypoglycaemia.
Participant Demographics
Participants were insulin-naïve adults with type 2 diabetes, aged 35 and older.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website